Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $34,974.63 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 6,441 shares of the firm’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $5.43, for a total transaction of $34,974.63. Following the completion of the transaction, the insider now directly owns 85,819 shares in the company, valued at approximately $465,997.17. This represents a 6.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Linda Llewelyn also recently made the following trade(s):

• On Wednesday, January 15th, Linda Llewelyn sold 6,442 shares of Health Catalyst stock. The shares were sold at an average price of $5.80, for a total value of $37,363.60.
• On Monday, December 16th, Linda Llewelyn sold 6,442 shares of Health Catalyst stock. The stock was sold at an average price of $7.88, for a total value of $50,762.96.

Health Catalyst Stock Performance

HCAT stock opened at $5.23 on Friday. The stock’s 50 day simple moving average is $6.24 and its 200 day simple moving average is $7.30. Health Catalyst, Inc. has a 12-month low of $5.20 and a 12-month high of $9.24. The firm has a market cap of $318.25 million, a P/E ratio of -3.87 and a beta of 1.34. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32.

Analyst Upgrades and Downgrades

HCAT has been the subject of a number of analyst reports. Stephens upped their price objective on shares of Health Catalyst from $7.00 to $9.00 and gave the company an “equal weight” rating in a research report on Thursday, November 14th. Piper Sandler lowered their price objective on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a research note on Tuesday, February 11th. Canaccord Genuity Group cut their target price on Health Catalyst from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Tuesday, January 21st. Royal Bank of Canada reduced their target price on Health Catalyst from $9.00 to $7.00 and set a “sector perform” rating for the company in a research note on Wednesday, January 15th. Finally, Citigroup dropped their price target on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $10.20.

Institutional Trading of Health Catalyst

A number of institutional investors and hedge funds have recently modified their holdings of HCAT. Harbor Capital Advisors Inc. boosted its holdings in shares of Health Catalyst by 21.3% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,764 shares of the company’s stock valued at $96,000 after buying an additional 2,064 shares during the period. Group One Trading LLC raised its stake in Health Catalyst by 107.6% during the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock worth $31,000 after acquiring an additional 2,260 shares during the period. Creative Planning lifted its holdings in Health Catalyst by 13.2% in the third quarter. Creative Planning now owns 21,348 shares of the company’s stock worth $174,000 after acquiring an additional 2,486 shares during the last quarter. Two Sigma Securities LLC boosted its stake in Health Catalyst by 19.5% in the fourth quarter. Two Sigma Securities LLC now owns 17,510 shares of the company’s stock valued at $124,000 after acquiring an additional 2,862 shares during the period. Finally, Legato Capital Management LLC raised its position in shares of Health Catalyst by 3.7% during the 4th quarter. Legato Capital Management LLC now owns 87,992 shares of the company’s stock worth $622,000 after purchasing an additional 3,171 shares during the period. 85.00% of the stock is owned by institutional investors and hedge funds.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.